Tests of a new HIV drug on monkeys have shown promising results, scientists have said. The drug targets the HIV enzyme called integrase, which helps the virus invade immune cells and replicate. Researchers at the pharmaceutical company Merck & Co, which is developing the drug, published their results in Science. UK experts said drugs which blocked the action of the enzyme were “a promising new generation of anti-HIV drugs”.
